Here are the 10-Q quarterly reports from BCHTD (BCHTD) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow BCHTD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BCHTD filings page.
Birchtech Corp. reported stronger first-quarter activity but remains loss-making. Revenue rose to $4.24 million from $3.22 million, driven by higher product sales, while license revenue dropped to zero. Gross profit was $1.38 million, and the company recorded a net loss of $1.35 million, or $0.06 per share, compared with a $1.68 million loss a year earlier.
Liquidity improved significantly after a February–March underwritten stock offering of 6.85 million shares that generated gross proceeds of $16.44 million. Cash increased to $14.75 million at March 31, 2026, up from $2.25 million at year-end, and stockholders’ equity turned positive at $11.17 million. Management now believes existing cash and expected revenue can fund operations for at least 12 months.
The balance sheet includes a related-party profit share liability of $7.09 million, tied to future net litigation proceeds from enforcing Birchtech’s mercury-control patents. A final judgment of $78.40 million (including pre-judgment interest) was entered in December 2025 against certain CERT defendants, but it has not been recognized as an asset because collection remains uncertain and the defendants have appealed. Birchtech is also advancing water-treatment technologies for PFAS and PFOS, supported by new design centers in Pennsylvania and North Dakota.